Buscar
Mostrando ítems 941-950 de 1014
Artículo
Epidemiology of Barrett’s esophagus and esophageal adenocarcinoma in Spain. A unicentric study
(Aran Ediciones S.A., 2016)
Background: Barrett’s esophagus (BE) is an acquired disease defined by the presence of intestinal metaplasia with goblet cells in the distal esophagus. The prevalence of BE has increased dramati cally over the last ...
Artículo
How is inflammatory bowel disease managed in Spanish gastroenterology departments? The results of the GESTIONA-EII survey
(Aran Ediciones S.A., 2016)
Introduction: Not all national health centers include special ized units or clinicians devoted to inflammatory bowel disease. The goal of the survey was to gain an insight into the management of this disease within ...
Artículo
Initial experience with golimumab in clinical practice for ulcerative colitis
(Aran Ediciones S.A., 2016)
Background: Golimumab is a TNF-blocking agent indicated as a second-line therapy in ulcerative colitis. Purpose: To research the effectiveness and safety of golimumab in patients with ulcerative colitis in clinical ...
Artículo
Artículo
Repositioning salicylanilide anthelmintic drugs to treat adenovirus infections
(Nature Research, 2019-01-09)
The repositioning of drugs already approved by regulatory agencies for other indications is an emerging alternative for the development of new antimicrobial therapies. The repositioning process involves lower risks and ...
Artículo
Relationship between gastroenterologists and hospital pharmacists: the results of a national survey. The CONDIFA study
(Aran Ediciones S.A., 2020)
Introduction: project CONDIFA (“Consenso Digestivo-Far macia Hospitalaria”) aims to establish lines of agreement between both specialties in order to improve patient care and resource optimization. In this initial ...
Artículo
Vedolizumab response in inflammatory bowel disease. Two years of follow-up
(Aran Ediciones S.A., 2020)
Background: vedolizumab is an α4β7 integrin antagonist. The aim of this study was to evaluate the clinical response and remission rates with vedolizumab. Methods: this was a retrospective study of inflammatory bowel ...
Artículo
Population pharmacokinetics and pharmacodynamics of fosfomycin in non-critically ill patients with bacteremic urinary infection caused by multidrug-resistant Escherichia coli
(Elsevier, 2018)
Objectives: To describe the population pharmacokinetics of fosfomycin for patients with bacteraemic urinary tract infection (BUTI). The analysis identified optimal regimens on the basis of pharmacodynamic targets and ...
Artículo
Effectiveness and safety of ustekinumab dose escalation in Crohn’s disease: a multicenter observational study
(Aran Ediciones S.A., 2023)
Background: ustekinumab has proven effective in Crohn’s disease (CD). However, some patients will partially respond or lose response over time. Data supporting the effective ness of dose escalation in this scenario is ...
Artículo
Index of the Mayo Endoscopy and Ulcerative Colitis Endoscopy Index of Severity: are they equally valid?
(Aran Ediciones S.A., 2020)
Introduction: endoscopy plays an essential role in the management of patients with ulcerative colitis (UC), as it allows us to visualize and assess the severity of the dis ease. Different scores have been devised to ...